Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls

NCT05812339 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT05812339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05812339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls
Lead sponsor
University of Calgary
Phase
Observational
Overall status
Enrolling by invitation
Start date
November 1, 2022
Completion date
December 31, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabinoid hyperemesis syndrome, cyclical vomiting, diabetic gastroparesis, functional dyspepsia, gastroparesis, motility disorder